Stage III non-small cell lung cancer: escalation matters, but how?

Affiliations

Editorial

Aparna Madhukeshwar Hegde et al. Transl Lung Cancer Res. 2018 Apr.

. 2018 Apr;7(Suppl 2):S107-S110.

doi: 10.21037/tlcr.2018.03.02.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Dose-escalation of locally advanced non-small cell lung cancer with proton beam therapy.
Verma V, Chang JY. Verma V, et al. Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S280-S282. doi: 10.21037/tlcr.2018.04.08. Transl Lung Cancer Res. 2018. PMID: 30393622 Free PMC article. No abstract available.

Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
Chang JY, Verma V, Li M, Zhang W, Komaki R, Lu C, Allen PK, Liao Z, Welsh J, Lin SH, Gomez D, Jeter M, O'Reilly M, Zhu RX, Zhang X, Li H, Mohan R, Heymach JV, Vaporciyan AA, Hahn S, Cox JD. Chang JY, et al. JAMA Oncol. 2017 Aug 10;3(8):e172032. doi: 10.1001/jamaoncol.2017.2032. Epub 2017 Aug 10. JAMA Oncol. 2017. PMID: 28727865 Free PMC article. Clinical Trial.

1. Senan S, Brade A, Wang LH, et al. PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer. J Clin Oncol 2016;34:953-62. 10.1200/JCO.2015.64.8824 - DOI - PubMed
1. Bradley JD, Hu C, Komaki RU, et al. Long-Term Results of RTOG 0617: A Randomized Phase 3 Comparison of Standard Dose Versus High Dose Conformal Chemoradiation Therapy +/- Cetuximab for Stage III NSCLC. Int J Radiat Oncol 2017;99:S105 10.1016/j.ijrobp.2017.06.250 - DOI
1. Bradley JD, Bae K, Graham MV, et al. Primary Analysis of the Phase II Component of a Phase I/II Dose Intensification Study Using Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable Non–Small-Cell Lung Cancer: RTOG 0117. J Clin Oncol 2010;28:2475-80. 10.1200/JCO.2009.27.1205 - DOI - PMC - PubMed
1. Socinski MA, Blackstock AW, Bogart JA, et al. Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105. J Clin Oncol 2008;26:2457-63. 10.1200/JCO.2007.14.7371 - DOI - PubMed
1. Oshiro Y, Okumura T, Kurishima K, et al. High-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II study. J Radiat Res 2014;55:959-65. 10.1093/jrr/rru034 - DOI - PMC - PubMed